Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
The company has been in a very positive evolution with new CEO and mix of new and existing leadership team. Clear commitment to strong and positive culture, people, patients and results.
Quelle est la meilleure partie de votre programme de rémunération?
Fair evaluation of goals and receipt of bonus
Qu’est-ce qui vous rend le plus heureux au travail?
trial results that focus on patients
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
actively being evolved with clear commitment to people, teams and patients
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Actively evolved from past control and command to engaged, aligned and capable team!!
Quelles sont les meilleures choses à propos de votre équipe?
Increasingly aligned and capable with a strong commitment to work together and lack of politics
Other Employee Reviews for Karyopharm Therapeutics
×